SOD1 and metabolic dysfunction-associated steatotic liver disease: Comparedwith T2DM patients in the other groups, T2DM patients in the NAFLD group hadsignificantly higher BMI, DBP, serum lipids (TG and TC), and SOD (all p< 0.05).